Paper6561069
Enhanced K-cell activity in the peripheral blood of patients with malignant disease.
Bakács T and 5 others. Cancer Immunol Immunother, 1984. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Enhanced K-cell activity in the peripheral blood of patients with malignant disease. Papers, record 6561069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6561069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Neoplasms | Major topic |
| Antibody-Dependent Cell Cytotoxicity | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Sex Factors |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6166701 | Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6166701 | PubMed |
| 2 | 479605 | Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals. | J Immunol | 1979 | https://conductscience.org/library/papers/479605 | PubMed |
| 3 | 4159466 | The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes. | Vox Sang | 1965 | https://conductscience.org/library/papers/4159466 | PubMed |
| 4 | 832266 | Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. | Cancer Res | 1977 | https://conductscience.org/library/papers/832266 | PubMed |
| 5 | 7138766 | Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7138766 | PubMed |
| 6 | 6260947 | Lysis of alloantibody-sensitized human erythrocytes by peripheral blood mononuclear cells: heterogeneity of effector populations. | J Clin Lab Immunol | 1981 | https://conductscience.org/library/papers/6260947 | PubMed |
| 7 | 4179068 | Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. | Scand J Clin Lab Invest Suppl | 1968 | https://conductscience.org/library/papers/4179068 | PubMed |
| 8 | 6171028 | Selective enhancement of human mononuclear leucocyte cytotoxic function by interferon. | Scand J Immunol | 1981 | https://conductscience.org/library/papers/6171028 | PubMed |
| 9 | 306592 | Lymphocyte mediated natural cytotoxicity in neoplasia. | Oncology | 1978 | https://conductscience.org/library/papers/306592 | PubMed |
| 10 | 6219125 | Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1. | J Clin Immunol | 1983 | https://conductscience.org/library/papers/6219125 | PubMed |
| 11 | 7240748 | In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. | J Immunol | 1981 | https://conductscience.org/library/papers/7240748 | PubMed |
| 12 | 7216547 | In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background. | Int J Cancer | 1980 | https://conductscience.org/library/papers/7216547 | PubMed |
| 13 | 6185128 | Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6185128 | PubMed |
| 14 | 748180 | Is antibody-dependent cellular cytotoxicity an important mechanism of resistance to tumors in vivo? | Immunochemistry | 1978 | https://conductscience.org/library/papers/748180 | PubMed |
| 15 | 6765619 | Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. I. In vitro and in vivo treatment using normal, gamma-irradiated and immune-stimulated rat effector cells. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6765619 | PubMed |
| 16 | 7287227 | Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumor cells. | Int J Cancer | 1981 | https://conductscience.org/library/papers/7287227 | PubMed |
| 17 | 6965233 | Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remission. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6965233 | PubMed |
| 18 | 155876 | Cytotoxic effects of activated human monocytes and lymphocytes to anti-D-treated human erythrocytes in vitro. | Scand J Immunol | 1979 | https://conductscience.org/library/papers/155876 | PubMed |
| 19 | 408421 | Cytotoxic activity of human lymphocytes: quanitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics. | J Immunol | 1977 | https://conductscience.org/library/papers/408421 | PubMed |
| 20 | 956652 | HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. | J Immunol | 1976 | https://conductscience.org/library/papers/956652 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 2936448 | Immune surveillance and natural resistance: an evaluation. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/2936448 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6561069
GET https://conductscience.org/api/papers/v1/6561069/references?page=2